The Cooper Health System clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 0 with minor changes only.

1. Notable

   CHAI · Chronic Subdural Hematoma Treatment With Intra-Arterial…CHAI · Chronic Subdural Hematoma Treatment With Intra-Arterial Bevacizumab Injection

   Phase changed: Phase 1/2 → Phase 1

   Also in this update: Final enrollment: 10 participants — 7% of the 140 planned; Trial completed

   The Cooper Health System·Phase 1· NCT06510582· Registry history of NCT06510582 on ClinicalTrials.gov (opens the registry)

   Updated Oct 2, 2026

2. Notable

   PRC · Pre-Radiation Chemotherapy for Newly Diagnosed High-Grade…PRC · Pre-Radiation Chemotherapy for Newly Diagnosed High-Grade Glioma

   Recruitment opened

   The Cooper Health System·Phase 2· NCT07439172· Registry history of NCT07439172 on ClinicalTrials.gov (opens the registry)

   Updated Oct 9, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.